Concepedia

Publication | Closed Access

Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial

DOI

1K

Citations

25

References

2021

Year

Unknown Author(s)
The Lancet Oncology

References

YearCitations

Page 1